Eva Anfruns
About Eva Anfruns
Eva Anfruns is the General Manager Taiwan at Bristol-Myers Squibb and the General Manager Central East Asia at Celgene, with extensive experience in managing pharmaceutical operations across diverse regions.
Title
Eva Anfruns currently holds the position of General Manager Taiwan at Bristol-Myers Squibb, as well as General Manager Central East Asia at Celgene.
Education and Expertise
Eva Anfruns has a robust academic background with a Master of Business Administration from NYU Stern School of Business (1998-2000), a Master of Science from Universitat Politècnica de Catalunya (1998-2004), and another Master of Science from the University of Wollongong (2004). She also earned a Master's in Business Administration from IESE Business School (2007-2009).
Professional Background
Eva Anfruns's career spans significant roles in global pharmaceutical companies. She has worked at Celgene as Director of Hematology and Oncology New Launches for Emerging Markets and as Associate Director, B-Thalassemia Lead Emerging Markets. Prior to these roles, she focused on Partner Management and Business Development in Sub-Saharan Africa at Celgene. She also held several positions at GSK, including Head of Pharma for Burundi, Djibouti, and Rwanda, and Head of Oncology for Developing Countries, as well as Commercial Director of Oncology Emerging Markets. Her early career included roles in brand management and healthcare consulting at Eli Lilly and Accenture, respectively.
Oncology Leadership Roles
Eva Anfruns has substantial expertise in oncology, demonstrated through her leadership positions at both GSK and Celgene. At GSK, she was the Commercial Director for Oncology Emerging Markets and later managed oncology operations in developing countries. She continued to focus on oncology at Celgene, leading efforts to launch new hematology and oncology products in emerging markets.
Global Pharmaceutical Management
Eva Anfruns has managed pharmaceutical operations across various regions, including Taiwan, Central East Asia, and Sub-Saharan Africa. Her international experience encompasses directing pharmaceutical activities in countries like Burundi, Djibouti, Rwanda, and emerging markets, reflecting her extensive expertise in overseeing geographically diverse pharmaceutical operations.